Can We Make Old Drugs Great Again? The Relevance Of Licensing Generics
Share This:
                           

About The Author

Melek Simsek currently works at the Department of Gastroenterology and Hepatology, Vrije Universiteit Amsterdam. Melek does research in Gastroenterology and Hepatology. Their current project is 'Thioguanine and classical thiopurines in IBD: a new era for old drugs.'

                       

Can We Make Old Drugs Great Again? The Relevance Of Licensing Generics

Throughout a drug's life cycle, there is a continuous development of drug features and new uses beyond the initial or approved drug indication. Identifying new applications for existing drugs, a process also known as drug rediscovery, repositioning, or repurposing, may create alternative treatment options while bypassing costs and time involved with bringing a new drug to market. A great example of a rediscovered drug is "sildenafil." This drug was initially explored for the management of cardiovascular diseases, but due to...

Read more